CTEV
Claritev Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Last price
37.92
▲ 3.84 (11.27%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
34.08
Prev close
34.08
Day high
37.34
Day low
34.70
Volume
162.76K
Market cap
$631.63M
P/E (TTM)
—
52W range
11.50 – 74.07
Day trading desk
Gap from prior close
-0.00%
Prior close 34.08
VWAP
36.40
+4.19% from price
Relative volume
1.62×
Unusually busy
Session range
11.27%
34.08 – 37.92
Position in range
100%
Near session high
ATR (14D)
3.56
9.39% of price
Prior day high
35.00
PDH
Prior day low
33.92
PDL
Bid / ask spread
—
Quote not published
Session volume
194.52K
Avg 119.88K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.23%
-0.9%
1M
+60.16%
+56.4%
3M
+58.26%
+55.2%
6M
+60.16%
+49.1%
YTD
-12.82%
-25.1%
1Y
-43.59%
-63.6%
3Y
-47.06%
-121.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CTEV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.24M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | MISENCIK TIFFANI Officer |
SELL | 8.85K | $354.59K | Direct |
| Aug 10, 26 | MINTZ WILLIAM B Officer |
SELL | 8.43K | $288.68K | Direct |
| Jun 30, 26 | ALBINSON BROCK Officer |
STOCK | 3.65K | $0 | Direct |
| Jun 9, 26 | CAROL NUTTER Officer |
BUY | 875 | $24.86K | Direct |
| May 19, 26 | PRINCE JOHN MICHAEL Director |
BUY | 10.00K | $160.00K | Direct |
| May 18, 26 | KIM MICHAEL Officer |
BUY | 3.00K | $49.95K | Direct |
| May 18, 26 | DALTON TRAVIS Chief Executive Officer |
BUY | 20.92K | $343.51K | Indirect |
| Apr 29, 26 | KLAPSTEIN JULIE D Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | COLALUCA ANTHONY JR Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | KLEIN MICHAEL STUART Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | CLARKE RICHARD A Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | HARRIS C. MARTIN M.D. Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | PRINCE JOHN MICHAEL Director |
STOCK | 8.98K | $0 | Direct |
| Apr 29, 26 | KAP JASON LAMAR Director |
STOCK | 8.98K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DALTON TRAVIS |
Chief Executive Officer | — | Purchase |
GARIS DOUGLAS MICHAEL |
Chief Financial Officer | 272.57K | Purchase |
H&F CORPORATE INVESTORS VIII LTD. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
HOGGE JEROME |
Chief Operating Officer | 160.27K | Stock Award(Grant) |
KIM MICHAEL |
Officer | 185.88K | Purchase |
KLEIN MICHAEL STUART |
Director | 219.82K | Stock Award(Grant) |
KOZEL GERALD |
Officer | 57.89K | Stock Award(Grant) |
MINTZ WILLIAM B |
Officer | 71.19K | Sale |
MISENCIK TIFFANI |
Officer | 123.72K | Sale |
WHITE DALE A. |
Director | 361.73K | Stock Gift |
Fundamentals
Market cap$631.63M
Enterprise value$5.32B
Revenue (TTM)$994.67M
Gross profit$725.77M
EBITDA$539.46M
Net income$-283.11M
EPS (TTM)$-17.00
Free cash flow$102.99M
Total cash$14.37M
Total debt$4.69B
Book value / share$-17.39
Shares outstanding16.95M
Float5.65M
Short % of float9.04%
Dividend yield—
Beta (5Y)0.79
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.08
PEG ratio—
Price / sales—
Price / book—
EV / revenue5.35
EV / EBITDA9.86
Gross margin72.97%
Operating margin12.80%
Profit margin-28.46%
Return on equity—
Return on assets1.19%
Debt / equity—
Current ratio1.00
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $965.41M | $930.62M | $961.52M | $1.08B | +3.7% |
| Operating revenue | $965.41M | $930.62M | $961.52M | $1.08B | +3.7% |
| Cost of revenue | $316.37M | $303.45M | $295.62M | $204.10M | +4.3% |
| Gross profit | $649.05M | $627.17M | $665.90M | $875.62M | +3.5% |
| Selling, general & admin | $113.61M | $86.84M | $74.97M | $132.14M | +30.8% |
| Total operating expense | $559.03M | $518.92M | $494.98M | $541.44M | +7.7% |
| Operating income | $90.01M | $108.26M | $170.92M | $334.18M | -16.9% |
| Net interest income | -$390.46M | -$323.24M | -$324.98M | -$299.90M | -20.8% |
| Pre-tax income | -$373.08M | -$1.77B | -$107.06M | -$560.74M | +78.9% |
| Tax provision | -$88.80M | -$124.88M | -$15.36M | $12.17M | +28.9% |
| Net income | -$284.28M | -$1.65B | -$91.70M | -$572.91M | +82.7% |
| Net income to common | -$284.28M | -$1.65B | -$91.70M | -$572.91M | +82.7% |
| Basic EPS | -17.30 | -101.92 | -5.69 | -36.00 | +83.0% |
| Diluted EPS | -17.30 | -101.92 | -5.69 | -36.00 | +83.0% |
| EBIT | $18.94M | -$1.44B | $226.15M | -$257.34M | +101.3% |
| EBITDA | $467.40M | -$1.01B | $651.93M | $158.32M | +146.4% |
| Basic shares | 16.43M | 16.15M | 16.13M | 15.97M | +1.8% |
| Diluted shares | 16.43M | 16.15M | 16.13M | 15.97M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $16.81M | $16.85M | $71.55M | $334.05M | -0.2% |
| Cash & short-term investments | $16.81M | $16.85M | $71.55M | $334.05M | -0.2% |
| Accounts receivable | $127.61M | $89.76M | $76.56M | $78.91M | +42.2% |
| Total current assets | $224.37M | $175.51M | $193.59M | $446.74M | +27.8% |
| Property, plant & equipment | $340.29M | $308.75M | $287.11M | $257.07M | +10.2% |
| Goodwill & intangibles | $4.29B | $4.63B | $6.46B | $6.65B | -7.3% |
| Total assets | $4.89B | $5.15B | $6.96B | $7.37B | -5.1% |
| Total current liabilities | $261.36M | $213.79M | $166.74M | $175.84M | +22.2% |
| Current debt | $14.69M | $13.25M | $13.25M | $13.25M | +10.9% |
| Long-term debt | $4.58B | $4.51B | $4.53B | $4.74B | +1.6% |
| Total debt | $4.62B | $4.54B | $4.57B | $4.78B | +1.6% |
| Total liabilities | $5.06B | $5.07B | $5.26B | $5.58B | -0.2% |
| Retained earnings | -$2.43B | -$2.15B | -$499.31M | -$347.80M | -13.3% |
| Shareholder equity | -$173.90M | $84.02M | $1.71B | $1.79B | -307.0% |
| Working capital | -$36.99M | -$38.27M | $26.85M | $270.89M | +3.4% |
| Net tangible assets | -$4.46B | -$4.55B | -$4.75B | -$4.85B | +1.8% |
| Shares issued | 17.30M | 16.93M | 16.70M | 16.66M | +2.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$284.28M | -$1.65B | -$91.70M | -$572.91M | +82.7% |
| Depreciation & amortisation | $448.45M | $436.44M | $425.79M | $415.66M | +2.8% |
| Stock-based compensation | $27.82M | $26.64M | $18.02M | $16.74M | +4.4% |
| Change in working capital | -$28.87M | -$14.40M | -$21.93M | $55.34M | -100.5% |
| Operating cash flow | $117.32M | $107.62M | $171.72M | $372.36M | +9.0% |
| Capital expenditure | -$129.60M | -$118.12M | -$108.85M | -$89.73M | -9.7% |
| Investing cash flow | -$121.02M | -$118.12M | -$249.79M | -$104.45M | -2.5% |
| Share buybacks | $0 | -$10.37M | -$15.22M | $0 | +100.0% |
| Financing cash flow | $2.36M | -$41.31M | -$180.99M | -$115.74M | +105.7% |
| Free cash flow | -$12.28M | -$10.51M | $62.87M | $282.63M | -16.8% |
| End cash position | $28.34M | $29.67M | $81.49M | $340.56M | -4.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $257.48M | $244.68M | $246.55M | $245.96M | $241.57M | +5.2% |
| Operating revenue | $257.48M | $244.68M | $246.55M | $245.96M | $241.57M | +5.2% |
| Cost of revenue | $84.18M | $80.81M | $78.03M | $82.31M | $79.13M | +4.2% |
| Gross profit | $173.30M | $163.87M | $168.52M | $163.65M | $162.44M | +5.8% |
| Selling, general & admin | $29.63M | $34.31M | $3.16M | $41.65M | $24.89M | -13.6% |
| Total operating expense | $140.33M | $145.40M | $114.89M | $153.59M | $136.12M | -3.5% |
| Operating income | $32.97M | $18.47M | $53.63M | $10.07M | $26.32M | +78.5% |
| Net interest income | -$100.06M | -$99.36M | -$99.13M | -$100.76M | -$99.42M | -0.7% |
| Pre-tax income | -$76.65M | -$92.72M | -$106.92M | -$93.36M | -$82.93M | +17.3% |
| Tax provision | -$17.42M | -$19.16M | -$26.35M | -$23.61M | -$20.29M | +9.1% |
| Net income | -$59.23M | -$73.56M | -$80.57M | -$69.75M | -$62.64M | +19.5% |
| Net income to common | -$59.23M | -$73.56M | -$80.57M | -$69.75M | -$62.64M | +19.5% |
| Basic EPS | -3.49 | -4.41 | -4.88 | -4.23 | -3.81 | +20.9% |
| Diluted EPS | -3.49 | -4.41 | -4.88 | -4.23 | -3.81 | +20.9% |
| EBIT | $23.60M | $6.82M | -$7.51M | $7.87M | $16.81M | +246.0% |
| EBITDA | $134.87M | $118.47M | $104.77M | $120.49M | $128.83M | +13.8% |
| Basic shares | 16.96M | 16.69M | 16.53M | 16.48M | 16.45M | +1.6% |
| Diluted shares | 16.96M | 16.69M | 16.53M | 16.48M | 16.45M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.37M | $21.33M | $16.81M | $39.15M | $56.39M | -32.6% |
| Cash & short-term investments | $14.37M | $21.33M | $16.81M | $39.15M | $56.39M | -32.6% |
| Accounts receivable | $130.90M | $140.92M | $127.61M | $126.99M | $123.58M | -7.1% |
| Total current assets | $236.42M | $242.27M | $224.37M | $257.46M | $247.14M | -2.4% |
| Property, plant & equipment | $372.58M | $357.15M | $340.29M | $330.29M | $323.41M | +4.3% |
| Goodwill & intangibles | $4.12B | $4.20B | $4.29B | $4.37B | $4.46B | -2.0% |
| Total assets | $4.76B | $4.84B | $4.89B | $4.99B | $5.07B | -1.6% |
| Total current liabilities | $237.51M | $189.56M | $261.36M | $213.32M | $253.14M | +25.3% |
| Current debt | $14.69M | $14.69M | $14.69M | $14.69M | $14.69M | 0.0% |
| Long-term debt | $4.66B | $4.70B | $4.58B | $4.62B | $4.61B | -0.9% |
| Total debt | $4.69B | $4.73B | $4.62B | $4.65B | $4.65B | -0.9% |
| Total liabilities | $5.05B | $5.07B | $5.06B | $5.09B | $5.11B | -0.4% |
| Retained earnings | -$2.56B | -$2.50B | -$2.43B | -$2.35B | -$2.28B | -2.4% |
| Shareholder equity | -$294.56M | -$241.14M | -$173.90M | -$101.83M | -$39.91M | -22.2% |
| Working capital | -$1.09M | $52.70M | -$36.99M | $44.14M | -$6.00M | -102.1% |
| Net tangible assets | -$4.41B | -$4.45B | -$4.46B | -$4.47B | -$4.50B | +0.7% |
| Shares issued | 16.94M | 17.74M | 17.30M | 17.25M | 17.21M | -4.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$59.23M | -$73.56M | -$80.57M | -$69.75M | -$62.64M | — | +19.5% |
| Depreciation & amortisation | $111.27M | $111.65M | $112.28M | $112.62M | $112.02M | — | -0.3% |
| Stock-based compensation | $7.38M | $6.89M | $7.80M | $6.99M | $6.71M | — | +7.0% |
| Change in working capital | $46.39M | -$79.97M | $49.14M | -$73.39M | $35.13M | — | +158.0% |
| Operating cash flow | $92.67M | -$45.78M | $66.29M | $19.86M | $61.24M | — | +302.4% |
| Capital expenditure | -$38.08M | -$46.77M | -$29.91M | -$36.20M | -$24.62M | — | +18.6% |
| Investing cash flow | -$38.08M | -$46.77M | -$34.66M | -$22.87M | -$24.62M | — | +18.6% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$61.64M | $98.93M | -$53.93M | -$13.63M | -$3.23M | — | -162.3% |
| Free cash flow | $54.59M | -$92.55M | $36.38M | -$16.35M | $36.61M | — | +159.0% |
| End cash position | $27.68M | $34.73M | $28.34M | $50.65M | $67.29M | — | -20.3% |
Options analytics
Put / call volume
10.80
Put-heavy session
Put / call open interest
2.55
Positioning, not flow
Max pain
40.00
+7.3% from spot
ATM implied vol
97.4%
Nearest strike to spot
Skew (10% OTM)
+11.1%
Puts bid over calls
Call volume
5
Contracts, this expiry
Put volume
54
Contracts, this expiry
Heaviest call OI
25.00
11 contracts
Heaviest put OI
40.00
34 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.33 | -2.94 | -320.9% |
| Mar 2026 | 1.38 | -3.30 | -338.9% |
| Dec 2025 | 0.85 | -3.19 | -475.2% |
| Sep 2025 | -3.55 | -4.23 | -19.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.71 | 1 | $256.46M | +4.3% |
| Next quarter | 1.72 | 1 | $256.64M | +4.1% |
| Current year | 5.81 | 1 | $1.02B | +5.2% |
| Next year | 7.33 | 1 | $1.07B | +5.2% |
Analyst targets & ownership
Mean target$45.83
High target$73.00
Low target$30.00
Implied upside20.87%
Analyst count6
ConsensusBUY
Strong buy / Buy2 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders7.30%
Held by institutions89.96%
Institutions holding152
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36.24
+4.64% from price
SMA 20
30.64
+21.64% from price
SMA 50
30.49
+22.24% from price
SMA 100
26.51
+43.02% from price
SMA 200
29.13
+27.94% from price
EMA 12
34.37
+10.34% from price
EMA 26
31.98
+18.59% from price
EMA 50
30.10
+25.96% from price
RSI (14)
61.5
Neutral
MACD (12,26,9)
2.39
Hist 0.56
ATR (14)
3.56
9.56% of price
Realised vol 30D
113.5%
Annualised
Bollinger upper
43.06
20, 2σ
Bollinger lower
18.22
20, 2σ
50 / 200 cross
Golden
30.49 vs 29.13
Trend bias
Above 200
+27.94%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.29
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
113.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-81.4%
Peak to trough
Max drawdown 5Y
-98.0%
Peak to trough
ATR 14
3.56
9.56% of price
Beta (reported)
0.79
5Y monthly, from filing
Short interest
Shares short
922.67K
Prior 976.65K
Change vs prior
-5.5%
Shorts covering
% of float
9.04%
Normal
% of shares out
5.45%
Against total outstanding
Days to cover
9.2
Crowded exit
Float
5.65M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 12, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 10, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 10, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 29, 26 | Canaccord Genuity | INITIATED | — | Buy |
| Apr 24, 26 | Barclays | INITIATED | — | Overweight |
| Mar 19, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 25, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Feb 24, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Feb 24, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jan 9, 26 | Citigroup | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:40
Split dateSep 23, 2024
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-07-06
Corporate Changes & Voting Matters
8-K · 2026-06-22
Corporate Changes & Voting Matters
8-K · 2026-05-18
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-04-30
Proxy Statements
DEF 14A · 2026-03-20
Corporate Changes & Voting Matters
8-K · 2026-03-16
Headlines
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Business Wire · 6d ago
Claritev (CTEV) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks
Simply Wall St. · 10d ago
Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing
MT Newswires · 11d ago
Claritev Corporation Q2 2026 Earnings Call Summary
Moby · 15d ago
Claritev Q2 Earnings Call Highlights
MarketBeat · 16d ago
Claritev Corp (CTEV) (Q2 2026) Earnings Call Highlights: Record Bookings and AI-Driven Growth ...
GuruFocus.com · 16d ago
Claritev Beats Second-Quarter Expectations and Raises Full-Year Guidance
InvestorsHub · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.